September 7, 2021
September is a multicolored ribbon month. MOASC encourages your support of these agencies and your continued fight against: Childhood cancer, Uterine cancer, Leukemia, Lymphoma, Ovarian cancer, Prostate cancer and Thyroid cancer.
Please continue to read the California Oncology Weekly and, this month, plan to attend and participate in the meetings and programs presented for you on these disease types. Thank you.
This Weekly's Hot Topics
  • YOUR ACTION IS NEEDED NOW! Avert a combined 9.75% cut in the Medicare physician payment system. National News

  • TOMORROW! September 8, Enhancing Personalized Medicine in Advanced Ovarian Cancer MOASC News/ MOASC Programs

  • September 11, Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myelomas 2021 ANCO News

  • September 13, comments due for CMS’ proposed rule on the Medicare Physician Fee Schedule (PFS) updates for calendar year (CY) 2022 Medicare News/CMS News

  • September 14, comments due for ICER assessment of the comparative clinical effectiveness and value of plinabulin and trilaciclib for the prevention of chemotherapy-induced neutropenia. National News
Never fight an insurance company again! Impiricus is a new platform for oncologists to access resources and get patients on therapy. Get access to grants, samples, information and more. Submit prior authorization and patient assistance requests in under 30 seconds with Impiricus’ digital interface. Impiricus does all the hard work, but keep you in the loop. Free Figs and Medelita white coats when signing up at: (use sign up code MOASC).
MOASC Programs - Save the Dates - All Times are Pacific
TOMORROW September 8, 2021 at 5:30pm-PT. In recognition of Ovarian Cancer Awareness Month, MOASC, in collaboration with PeerView, presents a virtual conference on Enhancing Personalized Medicine in Advanced Ovarian Cancer. Listen to expert guidance on integrating the latest updates on PARP inhibitors and novel therapeutic innovations into your clinical practice. 
September 22, 5:30-6:30pm PDT, MOASC will host a live webinar on Prostate Cancer Awareness, with panel discussions on initial treatment of Metastatic Castration Sensitive Prostate Cancer/Increase in newly diagnosed; current thoughts on radiation for primary tumor in Metastatic Disease and new treatments in Castration Resistance Disease in conjunction with genomic testing/PARP inhibitors presented by: Ashkan Lashkari, M.D., MOASC President; Christopher DeSantis, California Urological Association; John Lam, M.D., Kaiser Permanente, Los Angeles; Nataliya Mar, M.D., Assistant Professor, UCI and Steven N. Seyedin, M.D., Assistant Clinical Professor, UCI. This event is complementary but registration is required. 
September 25, 2021, Cedars Sinai’s 2021 Annual Seminar for GI Nurses and Associates directs content to GI Nurses and Interdisciplinary Professionals.
October 2, 2021, 8am-12pm SAVE THE DATE for MOASC’s Spotlight On Oncology. MOASC Board member, Jason Zell, MD will moderate discussions on: Melanoma presented by Omid Hamid, MD; Genitourinary Cancer presented by Nataliya Mar, MD; Upper Gastrointestinal Cancer presented by Jennifer Valerin, MD; Lower Gastrointestinal Cancer presented by May T. Cho, MD; Lung Cancer presented by Misako Nagasaka, MD, and Breast Cancer presented by Ritesh Parajuli, M.D. 
October 29-30, the University of California San Diego invites you to their inaugural Delivering Discoveries: Updates in Oncology CME conference. The diagnosis and management of cancer patients is increasingly complex and requires multidisciplinary management. This 1.5 day event will address all aspects of cancer from basic science research, advances in clinical care, to community-based approaches that optimize prevention and interception. 
November 4 and November 10, SAVE THE DATE for MOASC’S Annual Practice Management Series! On November 4, 11:45am-3:00pm, the Administrator Track will provide topics as: Process Automation for Physician Practices – Physician practices of all sizes still rely on manual processes to get work done. From invoicing to moving data between systems, many practices still rely on paper and their human staff doing things the same old way. Manual processes are error-prone, time consuming, and generally inefficient. In this webinar we will investigate how new technologies are allowing even small physician practices to automate key business processes to streamline their businesses. We’ll talk about a new type of automation known as Robotic Process Automation (RPA) and how it fits into the process automation landscape. We’ll also talk about a few automation solutions on the market today and how they may help your practice automate key business operations; Dealing with Burnout/Employee Fatigue, and Lessons from Top Providers Using Scalable Remote Monitoring for Equitable Value-based Care How can executives avoid fragmentation and sustain virtual, patient-centric care while driving quality, outcomes, and financial returns? Learn how leading IDNs and physician groups clad their IT and remote monitoring strategies post-COVID for the benefit of providers and care management teams, while preparing for increasing Medicare Advantage, Direct Contracting, and other alternative payment models. Attendees will be able to: Examine the approaches and strategic rationale behind five leading organizations’ approaches to maintaining virtual care flexibility without settling for a K-shaped health equity trajectory. Explain the imminent value-based care drivers forcing health systems to scale “care outside the four walls,” and associated tech. & operational preparation. Implement a tactical framework to bridge the digital divide using the right clinical licenses and technologies for the right populations and contracts. Bonus: Identify the most common pitfalls when attempting to scale engagement throughout vulnerable populations.
On November 10, 11:45am-3:00pm, the Biller Track will hear experts speak on: Revenue is a vital key to the success of every oncology practice and cancer center – Many practices are leaving substantial revenue “on the table.” Whether it’s due to coding or billing issues, the constant changes in the rules, denials or staff turnover, significant missed revenue for over 98% of practices; Positioning Your Physician Organization for Financial Success in Times of Change – This webinar will focus on revenue cycle considerations that can help physicians develop a strategy for long-term financial success, and 2022 Billing with  Bobbi Buell.
Ample opportunity will be afforded the attendees to spend time Networking in Zoom Room with Sponsors
California News
September 23, 2021, CMA is hosting a webinar to provide physician practices the information they need to avoid billing challenges to two of the most pressing issues facing medical practices at this stage of the COVID-19 pandemic: Telehealth and COVID-19 vaccine administration. Speakers will provide a brief overview of the current federal and state telehealth flexibilities in place as a result of the COVID-19 pandemic.
Medicare News
Noridian News
International Classification of Diseases, 10th Revision (ICD-10) and Other Coding Revisions NCDs -- January 2022 CR12399 tells you about updates of ICD-10 conversions and other coding updates specific to National Coverage Determinations (NCDs).
Noridian Programs
September 8, Additional Documentation Request (ADR) Pre-Pay A/B webinar is a medical review, data-driven program to educate providers on what to do with prepay Additional Documentation Requests (ADRs) and the timeframes involved with valuable resources.
September 9, the End Stage Renal Disease (ESRD) A/B Coverage webinar is intended for Medicare Part A and B Providers and will include: Medicare Eligibility and Enrollment; Coverage Regulations - Items and Services; Coding and Reimbursement Guidance, CMS and Noridian Resources. 
September 22 – 23, Noridian invites you to experience their Virtual Fall Symposium. Meet and engage with your provider education Part A and B team members, where you may pick and choose which sessions you're interested in attending. Each session will be 55 minutes long and you will be required to sign up for each session provided.
CMS News
September 13, 2021 by 2:00pm PDT, comments are due for CMS’ proposed rule on the Medicare Physician Fee Schedule (PFS) updates for calendar year (CY) 2022. The PFS Proposed Rule announces planned policies for the sixth and future years of the Quality Payment Program (QPP) established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
October 5, 2021, 10am PDT, join Bobbi Buell for a free webinar on the Proposed Outpatient Prospective Payment System Rule which is slated to start January 1, 2022.
CMS released an update to the Medicare Provider Payment and Utilization Public Use Files with data from 2019. These data files summarize the utilization and payments for procedures, services, and prescription drugs provided to Medicare beneficiaries by specific inpatient and outpatient hospitals, physicians, other practitioners and suppliers.
CMS has made available the latest edition of the MLN Connects.
A major provision of the No Surprises Act that would require health professionals to give good-faith estimates on costs of procedures to patients who have insurance has been delayed by the CMS.
National News
September 14, 2021, 2pm PDT is the deadline for comments to the Institute for Clinical and Economic Review (ICER) assessment of the comparative clinical effectiveness and value of plinabulin (BeyondSpring Pharmaceuticals) and trilaciclib (Cosela™, G1 Therapeutics) for the prevention of chemotherapy-induced neutropenia. BeyondSpring Pharmaceuticals announced the submission of a New Drug Application (NDA) for plinabulin, and the FDA is expected to respond by late 2021. The assessment will be publicly discussed during a meeting of the California Technology Assessment Forum (CTAF) in April 2022, where the independent evidence review panel will deliberate and vote on evidence presented in ICER’s report. All interested stakeholders are encouraged to submit comments and suggested refinements to the scope to ensure all perspectives are adequately considered. 
September 14, 2021, 10:00am PDT, the federal Office of the National Coordinator for Health Information Technology (ONC) is hosting a webinar to discuss the information blocking requirements of the 21st Century Cures Act. The webinar is a physician-focused presentation covering key aspects of the regulations focused on information blocking.
YOUR ACTION IS NEEDED NOW! With Congress set to return to Washington, DC in the coming weeks, there is much work to be done to avert a combined 9.75% cut in the Medicare physician payment system. If left unchecked these cuts could cause a serious disruption in patient access to care. Reps. Ami Bera, M.D. (D-CA) and Larry Bucshon, M.D. (R-IN) recently circulated a Dear Colleague letter highlighting the financial uncertainty within the Medicare payment system and the dangers these cuts could have on physicians’ ability to provide quality care for their patients if Congress fails to enact legislation to address these problems. They’re asking their colleagues in the House of Representatives to add their names to this letter and you can too, by contacting your representative and ask them to SIGN-ON NOW! It takes just a few moments to do to save cancer patients.
H.R.4414 – Cancer Care Planning & Communications Act of 2021 or CCPCA, is a bipartisan legislation, introduced in the House of Representatives and referred to the Committee on Energy and Commerce, in addition to the Committee on Ways and Means, to establish a Medicare service for cancer care planning. Cancer care planning has been identified as an element of quality cancer care for all Americans. The National Academy of Medicine, medical professional societies, and cancer patients have embraced the idea that all patients should receive a treatment plan from the cancer care team.
Health insurers are still covering COVID-19 vaccines and medically necessary COVID-19 tests, but they have started to roll back coverage of tests for other purposes, such as travel, work and participation in social events. Now that vaccines are widely available, insurers are also treating the costs of health care for COVID-19 as they do for any other illness, meaning treatment is subject to deductibles, copayments and coinsurance, even for people who have been vaccinated or who can't be vaccinated due to age or a health condition.
A study in the Journal of the American Geriatrics Society found older patients with multiple chronic conditions who read clinical notes in their EHRs were more likely than their peers without a chronic condition to say access to clinical notes made them feel more empowered and helped them adhere to their prescriptions. The findings, based on a cross-sectional survey of patient portal users older than 65 at three health care organizations, also revealed that reading clinical notes did not cause confusion for most patients.
The physician controls this. Clinical documentation improvement departments that monitor patient safety indicators already have a foundation for monitoring performance on reducing hospital-acquired conditions under the Hospital-Acquired Conditions Reduction Program. The HACRP reduces Medicare payments to hospitals based on performance on HAC measures, and data collected for the program is publicly reported.
Affiliate Association News
On September 13 -14, 2021, you will not want to miss the ACCC Community Oncology Research Institute (ACORI) Call to Action Summit.
ACS News

American Cancer Society Cancer Action Network prepares to mark 20 years since it was founded in 2001. ACS CAN reflects on what the past two decades have meant: incredible impact, momentous growth, significant public policy and grassroots milestones, and countless fond memories with volunteer advocates and colleagues. Their 20th Anniversary Celebration on September 29th, is a free virtual event featuring fun trivia about ACS CAN’s past, present and future! ACS CAN thanks you for your ongoing support of their lifesaving mission.
September 11 @ 9:00am - 12:30pm PDT, don’t miss ANCO's second virtual offering of Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myelomas 2021. Faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses. Registration is limited to 50 HCP and a limited number of representatives from sponsoring companies.
UC Davis is conducting a Medical Oncologist Survey. If you are a medical oncologist, we'd like to invite you to participate in a survey about genetic counseling and for the chance to win an iPad. Please contact with any questions.

September 13-14, 2021 is the virtual  ASCO Quality Training Program (QTP) summer 2021 course. Meeting 3 on December 10, 2021 will be a hybrid virtual and in-person program.
September 10-11 is the application deadline for the Young Investigator Award (YIA) and Young Investigator Award Drug Development. The YIA provides funding to promising investigators to encourage and promote quality research in clinical oncology.
ASH News

September 10-11 the 2021 ASH Meeting on Hematologic Malignancies will take place at the Hilton Chicago and online as a virtual meeting. Hear top hematology experts present cutting-edge science, provide out-of-the-box treatment approaches, and answer challenging patient care questions during topic-based “How I Treat” presentations and panel discussions. Those who register for the in-person experience will also receive complimentary access to the meeting’s virtual platform.
On October 4, 1-2pm PDT, ASH is hosting the final of their new series titled the ASH Advocacy Webinar Series, Working with Advocacy Groups and Coalitions: How to Amplify Your Voice in Washington. ASH is committed to educating its members on how to become effective advocates for hematology research and practice. Registration is free and open to all interested. 
COA News

COA has published their August 2021 Update, Pushing Back Against Mandatory Models.
Industry News
BeiGene announced the FDA approval of BRUKINSA® (zanubrutinib) for adult patients with Waldenström’s macroglobulinemia (WM). The ASPEN trial provided compelling evidence that BRUKINSA is a highly active BTK inhibitor in Waldenström’s macroglobulinemia, and compared to the first-generation BTK inhibitor, showed improved tolerability across a number of clinically important side effects. 
Incyte Corp. strives to provide assistance to physicians and patient education through their patient webinar programs. Please share this invitation with your patients and their caregivers who have been diagnosed with myeloproliferative neoplasms (MPN), including Polycythemia Vera, Essential thrombocythemia and Myelofibrosis. They will hear from Incyte Oncology Clinical Nurse Educators about MPNs. There are four live webinars, September 21 & 22 to choose from. Thank you.
Merck announces a label update for KEYTRUDA, Merck’s anti-PD-1 therapy, for its indication in first-line advanced urothelial carcinoma (bladder cancer). The FDA has converted this indication from an accelerated to a full (regular) approval. In addition, as part of the label update, this indication has been revised to be for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who are not eligible for any platinum-containing chemotherapy.
The Medical Oncology Association of Southern California (MOASC) is a leading oncology society that advances and protects the ability of cancer patients to obtain, and the ability of the oncology physicians to provide, optimal cancer care. The material contained in the California Oncology Weekly is intended as general information for MOASC members. Because diagnostic, treatment, contracting, coding, and billing decisions should be made on a case-by-case basis, any such information contained in the California Oncology Weekly may not apply in any given situation. Members are encouraged to contact their own consultants or advisors to obtain specific advice on matters relating to contracting, coding, and billing. The information contained in California Oncology Weekly should not be used as a substitute for such advice. This publication provides a summary of regulations affecting oncology and its business practices. Reading this newsletter does not substitute for understanding regulations and verifying the validity of every claim. This information is time-sensitive and is subject to change. MOASC accepts no liability for any statements or articles herein. CPT codes are owned and trademarked by the American Medical Association. All Rights Reserved.